Cargando…
Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry
In 2018, the Medicare Part D catastrophic threshold is $5000 in out-of-pocket total drug spending incurred by the beneficiary. Above this, Medicare pays 80%, prescription drug plans (PDPs) pay 15%, and beneficiaries pay a 5% copay. However, recent growth in catastrophic spending is caused by expensi...
Autores principales: | Padula, William V., Ballreich, Jeromie, Anderson, Gerard F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244621/ https://www.ncbi.nlm.nih.gov/pubmed/30058011 http://dx.doi.org/10.1007/s40258-018-0417-3 |
Ejemplares similares
-
Provider and Patient Characteristics of Medicare Beneficiaries Who Are High-Risk for COVID-19 Mortality
por: Ballreich, Jeromie, et al.
Publicado: (2021) -
Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
por: van der Pol, Karel H., et al.
Publicado: (2023) -
Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
por: Parikh, Ravi B., et al.
Publicado: (2022) -
Vaccination of chickens against coccidiosis ameliorates drug resistance in commercial poultry production
por: Chapman, H. David, et al.
Publicado: (2014) -
Using Health Economics to Inform Immunization Policy Across All Levels of Government
por: Rafferty, Ellen, et al.
Publicado: (2022)